Where to Inject Wegovy Shot: A Comprehensive Guide

Last reviewed: July 9, 2026

Last updated: July 9, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide works by delivering medication into the fatty layer beneath your skin, where it enters the bloodstream gradually over seven days. Proper injection site selection and technique directly impact medication effectiveness and injection comfort. This guide walks through approved sites, rotation strategies, and safety practices used in clinical GLP-1 therapy.

Approved Semaglutide Injection Sites for Weekly Dosing

Semaglutide injections are administered into subcutaneous tissue—the layer of fat between skin and muscle. Four anatomical areas are approved by manufacturers: the abdomen (belly), thigh, upper arm, and buttock. Each location offers reliable absorption when proper depth and technique are used. The abdomen around the navel offers the fastest absorption rate, though all four sites produce consistent clinical results when rotated properly.

The abdominal injection area extends from below the ribs to above the hip bone, but should avoid a two-inch circle around the navel itself. The outer thigh provides a convenient self-injection site with stable absorption timing. Upper arm injections work best when another person assists, as precise needle placement is harder to achieve alone. Buttock injections are less common for weekly dosing but remain a valid option when other sites need rest.

Injection Site Rotation: Why It Matters for Long-Term Treatment

Rotating injection sites prevents lipodystrophy—abnormal fat accumulation or loss that can develop when the same location receives repeated injections over months. Clinical data shows patients who rotate sites experience more consistent medication absorption and fewer localized tissue reactions. A practical rotation strategy involves selecting one site per week: abdomen week one, thigh week two, arm week three, and buttock week four, then repeating the cycle.

Spacing injections at least one inch apart within the same anatomical area reduces inflammation and maintains tissue integrity. Some patients find it helpful to map out injection points using a grid pattern or calendar to avoid accidental reuse of nearby spots. Over one year of weekly dosing, proper rotation ensures the medication distributes evenly across subcutaneous reserves, supporting stable blood glucose control and consistent appetite suppression.

Step-by-Step Semaglutide Injection Technique and Needle Depth

Begin by washing hands thoroughly and allowing the injection site to dry completely—moisture interferes with needle penetration and sterility. Pinch a fold of skin and fatty tissue between thumb and fingers to elevate the subcutaneous layer away from underlying muscle. Insert the needle at a 45- to 90-degree angle until it enters the fat layer; standard semaglutide pens use pre-calibrated needles designed for this depth. Push the injection button slowly over three to five seconds to allow medication to disperse evenly through surrounding tissue.

After injection, hold the needle in place for three additional seconds before withdrawing; this pause allows medication to settle and reduces back-flow toward the skin surface. Release the pinched skin and apply light pressure with a clean gauze pad for five to ten seconds if needed. Dispose of the used needle in an FDA-approved sharps container immediately—never reuse needles, as dull needles cause tissue trauma and medication leakage.

Managing Injection Site Reactions and When to Seek Care

Minor redness, bruising, or temporary soreness at the injection site is common during the first two to four weeks as your body adapts. These local reactions typically resolve within 24 hours and do not indicate medication failure or allergic response. Applying an ice pack before injection can reduce bleeding and bruising; a warm compress after injection may ease soreness. If redness persists beyond two days, swelling spreads across multiple sites, or warmth and drainage appear, contact your healthcare provider for evaluation.

Lipohypertrophy—thickened or lumpy fat deposits—develops when patients repeatedly inject into the same small area. This condition reduces medication absorption variability and can cause pain with injection. Avoiding the thickened areas for at least four to six weeks allows the tissue to normalize; PlexusDx patients working with their prescribing clinician can adjust injection timing during this recovery period. Persistent site reactions or signs of infection require medical evaluation to rule out contamination or needle-related injury.

PlexusDx Compounded Semaglutide: Consistent Dosing and Personalized Support

PlexusDx provides compounded semaglutide injections from licensed 503A compounding pharmacies, ensuring pharmaceutical-grade purity and accurate dosing for every injection. Unlike brand-name medications, PlexusDx pricing remains flat regardless of your dose level—your dose may need to go up, but your price won't. Compounded semaglutide is $189 per month month-to-month, or from $149/mo on the 6-month plan, making weekly GLP-1 therapy accessible without insurance or membership fees.

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Wegovy or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Can I inject semaglutide into muscle instead of fat?

No—intramuscular injection causes rapid, unpredictable absorption and increases side effects. Semaglutide is specifically designed for subcutaneous administration into fatty tissue, where it releases slowly over seven days and maintains stable blood levels.

How deep should the needle go into my skin?

Standard semaglutide needles are pre-calibrated to penetrate 5 to 8 millimeters, reaching subcutaneous fat without contacting muscle. Pinching the skin fold lifts the fat layer upward, ensuring proper needle depth at a 45- to 90-degree angle.

What if I accidentally inject into the same spot twice in one week?

A single accidental repeat injection causes minor tissue irritation and swelling but no serious harm. Resume your rotation schedule the following week and monitor the repeated site for increased soreness or bruising that resolves within 48 hours.

Does PlexusDx compounded semaglutide require different injection technique than brand-name versions?

No—PlexusDx compounded semaglutide from licensed 503A pharmacies uses identical injection sites, needle depths, and techniques as brand-name formulations. The medication composition and pharmacokinetics are clinically equivalent.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

The Precision Peptide Genetic Test analyzes 150+ genetic insights including GIPR variants, which influence your individual absorption rates and medication tolerance, but does not predict anatomical injection site preference. Your prescribing clinician uses genetic findings to optimize dose timing and progression, which may inform your rotation strategy.

Is there a cost difference between semaglutide injected at different sites?

No—PlexusDx compounded semaglutide pricing is flat at $189 per month regardless of injection site, dose level, or rotation pattern. All injection site selection decisions are clinical, not financial.

Related Reading

• Wegovy Shot
• Ro Wegovy
• Mochi Wegovy
• Noom Wegovy

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.